<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142820">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01763684</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.GK7</org_study_id>
    <nct_id>NCT01763684</nct_id>
  </id_info>
  <brief_title>Oxford Signature vs. Conventional Global Study</brief_title>
  <official_title>A Global Comparison of Signature Guides and Conventional Instrumentation in the Oxford Partial Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomet, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biomet, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <authority>Austria: Agency for Health and Food Safety</authority>
    <authority>Belgium: Federal Agency for Medicinal Products and Health Products</authority>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <authority>Australia: Human Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare alignment criteria in the Oxford Partial Knee using conventional
      instrumentation and Signature Custom Guides in order to determine if the use of the
      Signature Custom Guides results in a higher percentage of knees achieving optimal alignment.
      The study will also examine outcomes with high volume surgeons (&gt;30 cases/year) and low
      volume surgeons (&lt;10 cases/year).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objectives of this global clinical study are to collect data to assess the
      following clinical evidence parameters that were gathered from Biomet team members and KOL
      globally for this product:

        1. Evaluate the performance &amp; accuracy of the Oxford Partial Knee System with Signature
           Knee Guide in comparison to conventional instrumentation.

        2. Compare the accuracy of Signature Guides between two user profiles: high volume
           surgeons &amp; low volume surgeons in a global mix.

        3. Assess potential economic &amp; efficiency advantages in the short term and long-term: OR
           efficiency, patient quality of life and activity, clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Percentage of Knees Achieving Optimal Alignment</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average Number of Instrument Cases Used</measure>
    <time_frame>Right after surgery (up to 2 hours after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>Immediate Post-Operative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>10 Years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Function, Pain, and Range of Motion</measure>
    <time_frame>10 Years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Outcomes</measure>
    <time_frame>1 Year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mechanical Leg Alignment of Components (degrees)
Radiographic Failure due to either loosening or migration of components will be documented</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tourniquet Time</measure>
    <time_frame>Right after surgery (up to 2 hours after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant Sizing</measure>
    <time_frame>Right after surgery (up to 2 hours after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>Right after surgery (up to 2 hours after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion Rate</measure>
    <time_frame>Right after surgery (up to 2 hours after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Cell-Saver</measure>
    <time_frame>Right after surgery (up to 2 hours after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Drains Used</measure>
    <time_frame>Right after surgery (up to 2 hours after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Osteonecrosis</condition>
  <arm_group>
    <arm_group_label>Signature Custom Guides</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxford Partial Knee implanted using Signature Custom Guides</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Instrumentation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxford Partial Knee implanted using Conventional Instrumentation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Signature Custom Guides</intervention_name>
    <arm_group_label>Signature Custom Guides</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Instrumentation</intervention_name>
    <arm_group_label>Conventional Instrumentation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intended for use in individuals with osteoarthritis or Avascular necrosis limited to
             the medial compartment of the knee that is also lacking patellofemoral or lateral
             compartment disease.

          -  Use of cementless femoral fixation is permitted outside of the United States if it
             complies with all local, state, and/or national and international regulations. The
             same technique must be used consistently throughout the course of the study with all
             cases

          -  Patients 21 and over

        Exclusion Criteria:

          -  Use of Cementless Fixation in the United States

          -  Infection, sepsis or osteomyelitis

          -  Use in lateral compartment of the knee

          -  Rheumatoid arthritis or other forms of inflammatory joint disease

          -  Revision of failed prosthesis, failed upper tibial osteotomy, or post traumatic
             arthritis after tibial plateau fracture

          -  Insufficiency of the collateral, anterior, or posterior cruciate ligaments which
             would preclude stability of the device.

          -  Disease or damage to the lateral compartment of the knee

          -  Uncooperative patient or patient with neurologic disorders who is incapable of
             following directions

          -  Osteoporosis in the United States / Insufficient bone stock outside the United States

          -  Metabolic disorders which may impair bone formation

          -  Osteomalacia

          -  Distant foci of infections which may spread to implant site

          -  Rapid joint destruction, marked bone loss, or bone resorption apparent on
             roentgenogram

          -  Vascular insufficiency, muscular atrophy, neuromuscular disease.

          -  Incomplete or deficient soft tissue surrounding the knee.

          -  Charcot's disease

          -  A fixed varus deformity (not passively correctable) of greater than 15 degrees

          -  A flexion deformity greater than 15 degrees.

          -  Non-staged Bilateral patients

          -  Patients who refuse, cannot, or should not receive a CT or MRI. Since patients are
             randomized into treatment groups, all patients must be able to receive an MRI (should
             follow local MRI screening protocol). This excludes patients who have metal artifacts
             in the knee, patients who are too large to fit into the knee coil, patients with
             pacemakers, patients unable to lie still for the duration of the MRI, and patients
             who are claustrophobic.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Russell Schenck, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Biomet, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kelley McGuire, B.S.</last_name>
    <phone>(574) 372-1630</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Orthopedic and Sports Medicine Center</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Ganz</last_name>
      <phone>574-457-3606</phone>
      <email>kganz@osmc.com</email>
    </contact>
    <investigator>
      <last_name>Mark Klaassen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Orthopaedic Center</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Broomhead</last_name>
      <phone>301-251-1433</phone>
      <email>cbroomhead@theorthocentermd.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Hanna</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Missouri-Columbia Hospital and Clinics</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caleb Cheavens, RN, BSN</last_name>
      <phone>573-882-7615</phone>
      <email>cheavensj@health.missouri.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Aleto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Friend</last_name>
      <phone>919-684-6166</phone>
      <email>jennifer.friend@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Samuel Wellman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Bolognesi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joint Implant Surgeons</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sneller</last_name>
      <phone>614-221-6331</phone>
      <phone_ext>347</phone_ext>
      <email>snellerMA@joint-surgeons.com</email>
    </contact>
    <investigator>
      <last_name>Adolph Lombardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Morris, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Institute for Hip &amp; Knee Surgery</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78751</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Lebade</last_name>
      <phone>512-583-0226</phone>
      <email>mlabadie@orthoaustin.ecom</email>
    </contact>
    <investigator>
      <last_name>Eric Heinrich</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Dodgin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Orthopedics</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sean Little</last_name>
      <phone>804-270-1305</phone>
      <phone_ext>6843</phone_ext>
      <email>slittle@advancedortho.me</email>
    </contact>
    <investigator>
      <last_name>Bradley Ellison, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>February 27, 2014</lastchanged_date>
  <firstreceived_date>November 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Osteoarthritis, Knee</keyword>
  <keyword>Osteonecrosis</keyword>
  <keyword>Arthritis</keyword>
  <keyword>Knee Arthritis</keyword>
  <keyword>Knee Replacement</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteonecrosis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
